Your browser doesn't support javascript.
loading
Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression.
Chen, Sujun; Zhu, Guanghui; Yang, Yue; Wang, Fubo; Xiao, Yu-Tian; Zhang, Na; Bian, Xiaojie; Zhu, Yasheng; Yu, Yongwei; Liu, Fei; Dong, Keqin; Mariscal, Javier; Liu, Yin; Soares, Fraser; Loo Yau, Helen; Zhang, Bo; Chen, Weidong; Wang, Chao; Chen, Dai; Guo, Qinghua; Yi, Zhengfang; Liu, Mingyao; Fraser, Michael; De Carvalho, Daniel D; Boutros, Paul C; Di Vizio, Dolores; Jiang, Zhou; van der Kwast, Theodorus; Berlin, Alejandro; Wu, Song; Wang, Jianhua; He, Housheng Hansen; Ren, Shancheng.
Afiliação
  • Chen S; Department of Urology, Shanghai Changhai Hospital, Shanghai, P. R. China.
  • Zhu G; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Yang Y; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Wang F; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Xiao YT; Department of Urology, Shanghai Changhai Hospital, Shanghai, P. R. China.
  • Zhang N; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Bian X; Urology Institute of Shenzhen University, The Third Affiliated Hospital of Shenzhen University, Shenzhen University, Shenzhen, P. R. China.
  • Zhu Y; Department of Urological Surgery, The Affiliated Luohu Hospital of Shenzhen University, Shenzhen University, Shenzhen, P. R. China.
  • Yu Y; Department of Urology, Shanghai Changhai Hospital, Shanghai, P. R. China.
  • Liu F; Department of Urology, Shanghai Changhai Hospital, Shanghai, P. R. China.
  • Dong K; Department of Urology, Shanghai Changhai Hospital, Shanghai, P. R. China.
  • Mariscal J; East China Normal University, Shanghai, P. R. China.
  • Liu Y; Cancer Institute, Shanghai Urological Cancer Institute, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, P. R. China.
  • Soares F; Department of Urology, Shanghai Changhai Hospital, Shanghai, P. R. China.
  • Loo Yau H; Department of Urology, Shanghai Changhai Hospital, Shanghai, P. R. China.
  • Zhang B; Department of Urology, Cancer Hospital, Chinese Academy of Medical Sciences, Shanghai, P. R. China.
  • Chen W; Department of Urology, Shanghai Changhai Hospital, Shanghai, P. R. China.
  • Wang C; Department of Surgery, Division of Cancer Biology and Therapeutics, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Chen D; Department of Laboratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, P. R. China.
  • Guo Q; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Yi Z; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Liu M; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Fraser M; Novel Bioinformatics Co., Ltd, Shanghai, P. R. China.
  • De Carvalho DD; Novel Bioinformatics Co., Ltd, Shanghai, P. R. China.
  • Boutros PC; Novel Bioinformatics Co., Ltd, Shanghai, P. R. China.
  • Di Vizio D; Novel Bioinformatics Co., Ltd, Shanghai, P. R. China.
  • Jiang Z; Novel Bioinformatics Co., Ltd, Shanghai, P. R. China.
  • van der Kwast T; East China Normal University, Shanghai, P. R. China.
  • Berlin A; East China Normal University, Shanghai, P. R. China.
  • Wu S; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Wang J; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • He HH; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Ren S; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
Nat Cell Biol ; 23(1): 87-98, 2021 01.
Article em En | MEDLINE | ID: mdl-33420488
ABSTRACT
Prostate cancer shows remarkable clinical heterogeneity, which manifests in spatial and clonal genomic diversity. By contrast, the transcriptomic heterogeneity of prostate tumours is poorly understood. Here we have profiled the transcriptomes of 36,424 single cells from 13 prostate tumours and identified the epithelial cells underlying disease aggressiveness. The tumour microenvironment (TME) showed activation of multiple progression-associated transcriptomic programs. Notably, we observed promiscuous KLK3 expression and validated the ability of cancer cells in altering T-cell transcriptomes. Profiling of a primary tumour and two matched lymph nodes provided evidence that KLK3 ectopic expression is associated with micrometastases. Close cell-cell communication exists among cells. We identified an endothelial subset harbouring active communication (activated endothelial cells, aECs) with tumour cells. Together with sequencing of an additional 11 samples, we showed that aECs are enriched in castration-resistant prostate cancer and promote cancer cell invasion. Finally, we created a user-friendly web interface for users to explore the sequenced data.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Linhagem da Célula / Análise de Célula Única / Microambiente Tumoral / Transcriptoma Limite: Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Linhagem da Célula / Análise de Célula Única / Microambiente Tumoral / Transcriptoma Limite: Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article